Cargando…

A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis

With the increasingly early stage lung squamous cell carcinoma (LUSC) being discovered, there is an urgent need for a comprehensive analysis of the prognostic characteristics of early stage LUSC. Here, we developed an immune-related gene signature for outcome prediction of early stage LUSC based on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Tao, Lu, Zhiliang, Liu, Yu, Wang, Liyu, Tian, He, Zheng, Yujia, Zheng, Bo, Xue, Liyan, Tan, Fengwei, Xue, Qi, Gao, Shugeng, Li, Chunxiang, He, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226174/ https://www.ncbi.nlm.nih.gov/pubmed/34177903 http://dx.doi.org/10.3389/fimmu.2021.665407

Ejemplares similares

The therapeutic significance of the novel photodynamic material TPE-IQ-2O in tumors
por: Wang, Liyu, et al.
Publicado: (2020)

Immune profile of the tumor microenvironment and the identification of a four-gene signature for lung adenocarcinoma
por: Fan, Tao, et al.
Publicado: (2020)

ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC
por: Yang, Zhenlin, et al.
Publicado: (2021)

Transmembrane Protein-Based Risk Model and H3K4me3 Modification Characteristics in Lung Adenocarcinoma
por: Fan, Tao, et al.
Publicado: (2022)

Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis
por: Zhu, Mingchuang, et al.
Publicado: (2022)

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma
por: Sun, Nan, et al.
Publicado: (2022)

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis
por: Zhu, Mingchuang, et al.
Publicado: (2022)

A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma
por: Zheng, Yujia, et al.
Publicado: (2021)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma
por: Guo, Wei, et al.
Publicado: (2021)

Seventeen-Year Journey Working With a Master
por: Zhu, Jinfang
Publicado: (2018)

Specific organ metastases and prognosis in lung adenocarcinoma
por: Zhao, Ziran, et al.
Publicado: (2023)

RNA Sequencing of Tumor-Educated Platelets Reveals a Three-Gene Diagnostic Signature in Esophageal Squamous Cell Carcinoma
por: Liu, Tiejun, et al.
Publicado: (2022)

A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer
por: Luo, Dakui, et al.
Publicado: (2020)

Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma
por: Gao, Shugeng, et al.
Publicado: (2021)

Lipid metabolism–related lncRNA SLC25A21‐AS1 promotes the progression of oesophageal squamous cell carcinoma by regulating the NPM1/c‐Myc axis and SLC25A21 expression
por: Liu, Yu, et al.
Publicado: (2022)

Presentation of EGFR mutations in 162 family probands with multiple primary lung cancer
por: Li, Chunxiang, et al.
Publicado: (2021)

Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer
por: Zhao, Ziran, et al.
Publicado: (2023)

Comprehensive analyses of N (6)‐methyladenosine‐related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer
por: Luo, Yuejun, et al.
Publicado: (2022)

Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing
por: Song, Peng, et al.
Publicado: (2022)

The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma
por: Liu, Yu, et al.
Publicado: (2020)

Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for stage I lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2022)

m(6)A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma
por: Fan, Tao, et al.
Publicado: (2023)

A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer
por: Ren, Qianhe, et al.
Publicado: (2023)

TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma
por: Peng, Yue, et al.
Publicado: (2022)

Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2021)

A Multi-Center Validated Subtyping Model of Esophageal Cancer Based on Three Metabolism-Related Genes
por: Liu, Yu, et al.
Publicado: (2021)

The seventeen number ones
por: Dorsey, Tommy, 1905-1956
Publicado: (1990)

Seventeen papers on analysis
por: Aizerman, M A, et al.
Publicado: (1963)

Seventeen papers on analysis
por: Arnol'd, V I, et al.
Publicado: (1963)

Seventeen Supernumerary Teeth
por: Clapp, Dwight M.
Publicado: (1900)

An amino acid metabolism-based seventeen-gene signature correlates with the clinical outcome and immune features in pancreatic cancer
por: Hao, Jie, et al.
Publicado: (2023)

An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
por: Liu, Dan, et al.
Publicado: (2021)

Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma
por: Zheng, Bohao, et al.
Publicado: (2023)

Seventeen Cases of Scarlet Fever
por: Savage, P.
Publicado: (1928)

A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy
por: Zhang, Chaoqi, et al.
Publicado: (2020)

A Novel Signature of 23 Immunity-Related Gene Pairs Is Prognostic of Cutaneous Melanoma
por: Xue, Ya-Nan, et al.
Publicado: (2020)

Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma
por: Guo, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tt3jq8g5anhsj00g7a3qgc123m